Novavax execs cash out on stock buoyed by Covid-19 vaccine work
August 21, 2020 at 15:11 PM EDT
The sales follow recent developments in Novavax’s Covid-19 vaccine program that propelled its share price this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|